This is the first report of the miRNome of CML-CP CD34+CD38− fractions that distinguishes between CD26+ (BCR-ABL1+) and their CD26− (BCR-ABL1-) counterparts, providing valuable data for future studies. This evidence concerns the gene CD38 and chronic myelogenous leukemia, BCR-ABL1 positive.